<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>(Table is included in full-text article.)<z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> results from the replacement of the <z:mpath ids='MPATH_458'>normal</z:mpath> squamous lining of the oesophagus by a columnar epithelium </plain></SENT>
<SENT sid="1" pm="."><plain>It is the sole known <z:e sem="disease" ids="C0032927" disease_type="Neoplastic Process" abbrv="">premalignant condition</z:e> for oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>The annual <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> incidence of 1% in <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e>, calculated from published series, has been recently considered an overestimation owing to publication bias, and a 0.5% risk was proposed </plain></SENT>
<SENT sid="3" pm="."><plain>The prerequisite of the presence of <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> for the diagnosis of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e>, although widely accepted, is questioned by some authors </plain></SENT>
<SENT sid="4" pm="."><plain>How <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> incidence is influenced by requiring or not <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> for <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> diagnosis is unknown </plain></SENT>
<SENT sid="5" pm="."><plain>Most of the published studies included only (or preferentially) patients with long segments </plain></SENT>
<SENT sid="6" pm="."><plain>Data on <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> incidence in short segments (&lt;3 cm) are very scarce, but it is believed to be lower than in long segments </plain></SENT>
<SENT sid="7" pm="."><plain>The magnitude of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk influences cost effectiveness of surveillance of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Frequently, therapeutic intervention is performed when high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> is diagnosed, preventing progression to <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain>This could lead to an underestimation of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk in Barrett's surveillance studies </plain></SENT>
</text></document>